Bayer backs broadened effort to shield popular weedkiller from claims it failed to warn of cancer
A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its popular weedkiller ...
pharmaphorum3d
Bayer adds menopause drug to pipeline with KaNDy acquisition
Bayer is to buy UK-based KaNDy Therapeutics in a deal worth more than $800 million, adding the biotech’s menopause drug to its women’s health pipeline. Bayer will pay $425 million up front and ...